Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using<sup>89</sup>Zr-DFO-MSTP2109A Anti-STEAP1 Antibody
2019 · Journal of Nuclear Medicine · 60 citations
https://doi.org/10.2967/jnumed.118.222844
S
Sarah M. Cheal
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
102
Papers
1.8K
Citations
23
h-index
29
i10-index
Sarah M. Cheal is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Radiopharmaceutical Chemistry and Applications & Monoclonal and Polyclonal Antibodies Research & Medical Imaging Techniques and Applications. The author has an h-index of 23, co-authored 87 publications.
ORCID: 0000-0003-1720-8994Papers by this author
worksTargeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modeling
2016 · EJNMMI Research · 43 citations
https://doi.org/10.1186/s13550-016-0164-0
Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma
2018 · Theranostics · 38 citations
https://doi.org/10.7150/thno.26585
Radioimmunotherapy for peritoneal carcinomatosis: Preclinical proof of concept to clinical translation
2025 · Cell Reports Medicine · 2 citations
https://doi.org/10.1016/j.xcrm.2025.102040
Preclinical <sup>203/212</sup> Pb-DOTA–Based Pretargeted Radioimmunotherapy in Nude Mice Bearing Established Human Colorectal Cancer Xenografts
2026 · Journal of Nuclear Medicine · 0 citations
https://doi.org/10.2967/jnumed.125.270604
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat